Justification and Approval: Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization

Awarded Limited / Sole Source Justification Posted

Solicitation number
JA-20-08-00193
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
W81XWH21C0003 Federal contract award
Place of performance
Ut Usa

Notice details come from SAM.gov. Updated .

About this opportunity

This Limited/Sole Source Justification Notice from the Department of the Army Medical Command awards a sole source contract to BioFire Defense, LLC. The contract is for $863,843.76 to conduct sample type expansion studies of BioFire Defense's COVID-19 test under Emergency Use Authorization from 1 October 2020 to 30 November 2020. The goal of the studies is to expand the approved sample types for BioFire Defense's COVID-19 test beyond the current nasopharyngeal swab to address challenges with sample collection and availability of transport media. Market research determined that BioFire Defense is the only organization able to submit an amendment to the COVID-19 test's EUA to expand the approved sample types.

Notice text

Justification and Approval synopsis made in accordance with FAR 6.305.

Awarded contract W81XWH21C0003 to unknown vendor for unknown amount on 2020-10-14.

Files

Notice history

Notice Type Posted
This notice Latest Limited / Sole Source Justification
Notice of Intent: Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization Latest special notice Special Notice
Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors